Fig. 1.

Patient disposition. All numbers expressed are in thousands. *Excludes abatacept. ^†Based on MacLean’s positive predictive value of an administrative data-based algorithm for the identification of patients with RA [29]. b/tsDMARDs, biologic or targeted synthetic disease-modifying antirheumatic drugs; RA, rheumatoid arthritis